Publications
2025
Scholarly publications
2023
Scholarly publications
Faucher, Q., Stéphanie Chadet, Antoine Humeau, Sauvage, F.-L., Arnion, H., Gatault, P., Buchler, M., Roger, S., Lawson, R., Marquet, P., & Barin-Le Guellec, C. (2023). Impact of hypoxia and reoxygenation on the extra/intracellular metabolome and on transporter expression in a human kidney proximal tubular cell line. Metabolomics, 19. [DOI] [Repository]
Aouad, H., Faucher, Q., Sauvage, F.-L., Pinault, E., Barrot, C.-C., Arnion, H., Essig, M., & Marquet, P. (2023). A multi-omics investigation of tacrolimus off-target effects on a proximal tubule cell-line. Pharmacological Research, 192, Article 106794. [DOI] [Repository]
Faucher, Q., van der Made, T. K., De Lange, E., & Masereeuw, R. (2023). Blood-brain barrier perturbations by uremic toxins: key contributors in chronic kidney disease-induced neurological disorders? European Journal of Pharmaceutical Sciences, 187, 1-8. Article 106462. [DOI] [Repository]
Janaszkiewicz, A., Tóth, Á., Faucher, Q., Arnion, H., Védrenne, N., Barin-Le Guellec, C., Marquet, P., & Florent , D. M. (2023). Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale. Biomedicine and Pharmacotherapy, 160, 1-10. Article 114342. [DOI] [Repository]
2022
Scholarly publications
Jardou, M., Brossier, C., Kenza, G., Faucher, Q., & Lawson, R. (2022). Pharmacological hypothesis: A recombinant probiotic for taming bacterial β-glucuronidase in drug-induced enteropathy. Pharmacology Research and Perspectives, 10(5), 1-7. Article e00998. [DOI] [Repository]
Faucher, Q., Jardou, M., Brossier, C., Picard, N., Marquet, P., & Lawson, R. (2022). Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus? Frontiers in Endocrinology, 13, 1-9. Article 898878. [DOI] [Repository]
Janaszkiewicz, A., Tóth, Á., Faucher, Q., Marving , M., Chantemargue, B., Barin-Le Guellec, C., Marquet, P., & Florent , D. M. (2022). Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes. Scientific Reports, 12, 1-15. Article 7057. [DOI] [Repository]
Faucher, Q., Alarcan, H., Sauvage, F.-L., Forestier, L., Miquelestorena-Standley, E., Nadal-Desbarats, L., Arnion, H., Venhard, J.-C., Brichart, N., Bruyère, F., Marquet, P., & Barin-Le Guellec, C. (2022). Perfusate Metabolomics Content and Expression of Tubular Transporters During Human Kidney Graft Preservation by Hypothermic Machine Perfusion. Transplantation, 106(9), 1831-1843. [DOI] [Repository]
2020
Scholarly publications
Faucher, Q., Alarcan, H., Marquet, P., & Barin-Le Guellec, C. (2020). Effects of Ischemia-Reperfusion on Tubular Cell Membrane Transporters and Consequences in Kidney Transplantation. Journal of Clinical Medicine, 9(8), Article 2610. [DOI]
2019
Scholarly publications
Burat, B., Faucher, Q., Čechová, P., Arnion, H., Di Meo, F., Sauvage, FL., Marquet, P., & Essig, M. (2019). Cyclosporine A inhibits MRTF-SRF signaling through Na+/K+ ATPase inhibition and actin remodeling. FASEB BioAdvances, 1(9), 561-578. [DOI]